白细胞介素-1β、JAK2V617F突变与骨髓增殖性肿瘤中的炎症 - Suppr

Suppr

超能文献

Interleukin-1β, JAK2V617F mutation and inflammation in MPNs.

作者信息

Hermouet Sylvie, Hasselbalch Hans C

机构信息

Nantes Université, INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes, France.

Laboratoire d'Hématologie, CHU Nantes, Nantes, France.

出版信息

Blood Adv. 2024 Aug 27;8(16):4344-4347. doi: 10.1182/bloodadvances.2024013528.

DOI:10.1182/bloodadvances.2024013528

PMID:38985205

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11372809/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5974/11372809/754605ecfb01/BLOODA_ADV-2024-013528-gr1.jpg

相似文献

Interleukin-1β, JAK2V617F mutation and inflammation in MPNs.白细胞介素-1β、JAK2V617F突变与骨髓增殖性肿瘤中的炎症

Blood Adv. 2024 Aug 27;8(16):4344-4347. doi: 10.1182/bloodadvances.2024013528.

Myeloproliferative neoplasms in Budd-Chiari syndrome and portal vein thrombosis: a meta-analysis.布加综合征和门静脉血栓形成中的骨髓增殖性肿瘤：一项荟萃分析。

Blood. 2012 Dec 13;120(25):4921-8. doi: 10.1182/blood-2011-09-376517. Epub 2012 Oct 4.

Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.JAK2V617F 突变的骨髓增殖性肿瘤中的血栓形成。

Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):374-81. doi: 10.1177/1076029612453761. Epub 2012 Jul 23.

Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.在骨髓增殖性肿瘤的小鼠模型中，内皮细胞JAK2V617F突变会导致血栓形成、血管病变和心肌病。

J Thromb Haemost. 2020 Dec;18(12):3359-3370. doi: 10.1111/jth.15095. Epub 2020 Oct 5.

Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.临床视角下骨髓增殖性肿瘤中血栓形成的起源。

Blood. 2021 Mar 4;137(9):1145-1153. doi: 10.1182/blood.2020008043.

Circulating CD133+/–CD34– Have Increased c- Expression in Myeloproliferative Neoplasms.循环 CD133+/–CD34– 在骨髓增生性肿瘤中具有更高的 c-表达。

Turk J Haematol. 2023 Feb 28;40(1):28-36. doi: 10.4274/tjh.galenos.2022.2022.0343. Epub 2022 Dec 2.

[A novel quantitative JAK2V617F detection kit: prospective clinical performance study comparing MPN patients and healthy subjects].[一种新型JAK2V617F定量检测试剂盒：比较骨髓增殖性肿瘤患者和健康受试者的前瞻性临床性能研究]

Rinsho Ketsueki. 2018;59(6):669-674. doi: 10.11406/rinketsu.59.669.

Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice.致癌性 JAK2V617F 需要完整的 SH2 样结构域才能实现组成性激活，并在小鼠中诱导骨髓增殖性疾病。

Blood. 2010 Nov 25;116(22):4600-11. doi: 10.1182/blood-2009-07-236133. Epub 2010 Aug 9.

The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.JAK2V617F 突变对伴有门脉系统血栓形成的非费城染色体阴性慢性骨髓增殖性肿瘤患者的临床意义。

J Thromb Thrombolysis. 2012 Oct;34(3):388-96. doi: 10.1007/s11239-012-0738-2.

JAK2V617F mutations in myeloid malignancies: single center experience.髓系恶性肿瘤中的JAK2V617F突变：单中心经验

Prilozi. 2008 Dec;29(2):257-67.

引用本文的文献

Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP.从诊断角度看克隆性造血：CHIP的十年

Mol Diagn Ther. 2024 Nov;28(6):665-668. doi: 10.1007/s40291-024-00737-7. Epub 2024 Aug 20.

本文引用的文献

In vivo ablation of NF-κB cascade effectors alleviates disease burden in myeloproliferative neoplasms.体内消融 NF-κB 级联效应物可减轻骨髓增殖性肿瘤的疾病负担。

Blood. 2024 Jun 6;143(23):2414-2424. doi: 10.1182/blood.2023022804.

IL-1β promotes MPN disease initiation by favoring early clonal expansion of JAK2-mutant hematopoietic stem cells.白细胞介素-1β（IL-1β）通过促进 JAK2 突变造血干细胞的早期克隆扩张，促进 MPN 疾病的起始。

Blood Adv. 2024 Mar 12;8(5):1234-1249. doi: 10.1182/bloodadvances.2023011338.

Mutations, inflammation and phenotype of myeloproliferative neoplasms.骨髓增殖性肿瘤的突变、炎症与表型

Front Oncol. 2023 May 22;13:1196817. doi: 10.3389/fonc.2023.1196817. eCollection 2023.

Obesity-induced inflammation exacerbates clonal hematopoiesis.肥胖引起的炎症会加重克隆性造血。

J Clin Invest. 2023 Jun 1;133(11):e163968. doi: 10.1172/JCI163968.

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm.抑制白细胞介素-1β可减少 JAK2-V617F 驱动的骨髓增殖性肿瘤小鼠的骨髓纤维化和骨质硬化。

Nat Commun. 2022 Sep 13;13(1):5346. doi: 10.1038/s41467-022-32927-4.

Interleukin-1 contributes to clonal expansion and progression of bone marrow fibrosis in JAK2V617F-induced myeloproliferative neoplasm.白细胞介素-1 有助于 JAK2V617F 诱导的骨髓增殖性肿瘤中骨髓纤维化的克隆扩张和进展。

Nat Commun. 2022 Sep 13;13(1):5347. doi: 10.1038/s41467-022-32928-3.

Clonal hematopoiesis of indeterminate potential (CHIP): Linking somatic mutations, hematopoiesis, chronic inflammation and cardiovascular disease.克隆性造血不定潜能 (CHIP)：连接体细胞突变、造血、慢性炎症与心血管疾病。

J Mol Cell Cardiol. 2021 Dec;161:98-105. doi: 10.1016/j.yjmcc.2021.07.004. Epub 2021 Jul 21.

Ruxolitinib and interferon-α2 combination therapy for patients with polycythemia vera or myelofibrosis: a phase II study.芦可替尼与干扰素-α2 联合治疗真性红细胞增多症或骨髓纤维化患者：一项 II 期研究。

Haematologica. 2020 Sep 1;105(9):2262-2272. doi: 10.3324/haematol.2019.235648.

Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?干扰素与芦可替尼联合治疗真性红细胞增多症和骨髓纤维化：两种药物是否比一种更好？

Haematologica. 2020 Sep 1;105(9):2190-2191. doi: 10.3324/haematol.2020.256602.

Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms.NLRP3 炎性体相关基因的遗传多态性和表达与费城染色体阴性骨髓增殖性肿瘤有关。

Hum Immunol. 2020 Oct-Nov;81(10-11):606-613. doi: 10.1016/j.humimm.2020.09.001. Epub 2020 Sep 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验